Cancer is getting shier by the day.
The last thing I heard was the Syrosingopine synergic effect with metformin (Diabetes, cancer, hypertension treatment combo breaker)
Pre-clinical trials have been promising so far, though (especially the in-vitro and in vivo animal studies in lung tissue).

Retrospective studies show improvement in survival, but they can also show the contrary, depending on who pays them.